Jeremy Rudnick, M.d

This early-stage study aimed to test the safety of a personalized immune therapy for people with recurrent glioblastoma, an aggressive brain cancer. Researchers planned to collect patients' own immune cells, modify them to target cancer stem cells, and reinfuse them. The main goa…